Antonio Cubillo Gracián
- 36 years of experience
- Location: Spain, Madrid
Dr. Cubillo Gracián pioneered the liquid biopsy program in Spain. He uses molecular markers like EGFR, ALK, and ROS1 to create personalized cancer treatment plans.
- Head of Medical Oncology at Hospital Universitario HM Sanchinarro
- Director of Postgraduate Research at HM CIOCC USP CEU
- Co-investigator for the Start Madrid clinical trials program
- Specializes in molecular tumor analysis through advanced blood-based testing
- Associate Professor of Oncology at USP CEU university
- Read more





